Neuren Pharmaceuticals Competitors and Similar CompaniesClear all

Neuren Pharmaceuticals's competitors and similar companies include Delix Therapeutics, Autifony Therapeutics and SwanBio Therapeutics.

	Neuren Pharmaceuticals Neuren Pharmaceuticals is a company that develops therapies for debilitating neurodevelopmental disorders.	Delix Therapeutics Delix Therapeutics is a company developing small molecule drug compounds against mental disorders.	Autifony Therapeutics Autifony Therapeutics is a biotechnology company that develops new drugs to treat serious disorders of the central nervous system.	SwanBio Therapeutics SwanBio Therapeutics is a gene therapy company developing medicines for the treatment of neurological diseases.
Founding Date	Founding Date 1993	Founding Date 2019	Founding Date 2011	Founding Date 2018
Type	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech drug development genetics mental health therapy	Tags Healthcare biotech drug development mental health pharma therapy	Tags Healthcare biotech drug development mental health pharma therapy	Tags Healthcare biotech drug development genetics therapy
Locations	Locations Camberwell, AU HQ Auckland, NZ	Locations HQ	Locations Stevenage, GB HQ Padova, IT	Locations Philadelphia, US HQ Cambridge, US
Employees	Employees N/A	Employees 313% decrease	Employees 3017% decrease	Employees 625% decrease
Financial
Revenue (est.)	Revenue (est.) $64.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) £22.8m (FY, 2018)	Revenue (est.) N/A
Net income	Net income $30.4m (FY, 2025)	Net income N/A	Net income £16.2m (FY, 2018)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 70m (almost 5 years ago)	Latest funding round $ 12.3m (about 11 years ago)	Latest funding round $ 52m (about 6 years ago)
Total funding raised	Total funding raised $ 21.5m	Total funding raised $ 78m	Total funding raised $ 24.2m	Total funding raised $ 52m